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comprising the niche environment.[2] The 
ECM is a complex and heterogeneous net-
work of adhesive proteins and growth fac-
tors that support and guide cells.[3] Recent 
studies using material interfaces have 
demonstrated that cell behaviors, such as 
differentiation, can be controlled through 
characteristics such as substrate stiff-
ness,[4] nanotopography,[5] and chemistry.[6] 
However, these are static systems and thus 
can only act as highly reductionist repre-
sentations of in vivo ECM features.
There have been attempts to recapitu-
late the dynamic properties of the ECM 
using materials that react to external 
stimuli and ultimately alter the phenotype 
of the cells. Different types of triggering 
mechanisms have been utilized including 
light, either in 2D or 3D (hydrogels) cul-
ture systems, inducing irreversible or 
reversible protein-material interactions,[7–10] temperature,[11] 
and enzymes.[12] However, these systems are typically designed 
to reveal or hide cell binding sites to/from cells and this still 
falls short of the dynamic nature of complex niches hMSCs 
reside in in vivo. There is still a need to develop approaches 
where both the physical properties and biological composition 
of the ECM can be dynamically controlled to recapitulate the 
properties of the hMSC native microenvironment.
Bacteria can be genetically modified to express different pro-
teins which can be used to direct cell behavior and thus influence 
hMSC fate. Some authors have used bacterial secretion systems 
(e.g., Type III Secretion System (T3SS)) to directly inject transcrip-
tion factors in eukaryotic cells.[13] We propose that nonpathogenic 
bacteria, specifically the lactic bacteria Lactococcus lactis, can be 
utilized as a dynamic interface on materials to enable stem cell 
technologies. While use of materials containing bacteria appears 
counterintuitive in a system designed for eukaryotic cells, we show 
conditions for long term symbiosis of both cell populations within 
material systems. As well as being able to direct eukaryotic cell 
phenotype, bacteria interface with biomaterials of different phys-
ical properties enabling physical and biological control of hMSCs.
The control of hMSC fate is achieved functionalizing mate-
rial system through engineered L. lactis that express the III7–10 
fragment of the human fibronectin (FNIII7–10) that is known to 
support cell adhesion[14] and the bone morphogenetic protein 
2 (BMP-2—membrane-bound and secreted), a cytokine per-
taining to the transforming growth factor beta superfamily that 
can induce osteogenic differentiation in hMSCs.[15] We showed 
that the differentiation of MSCs occur on engineered L. lactis 
that express FN if BMP-2 is added exogenously in the culture 
Materials can be engineered to deliver specific biological cues that control 
stem cell growth and differentiation. However, current materials are still limited 
for stem cell engineering as stem cells are regulated by a complex biological 
milieu that requires spatiotemporal control. Here a new approach of using 
materials that incorporate designed bacteria as units that can be engineered to 
control human mesenchymal stem cells (hMSCs), in a highly dynamic-temporal 
manner, is presented. Engineered Lactococcus lactis spontaneously colonizes 
a variety of material surfaces (e.g., polymers, metals, and ceramics) and is able 
to maintain growth and induce differentiation of hMSCs in 2D/3D surfaces and 
hydrogels. Controlled, dynamic, expression of fibronectin fragments supports 
stem cell growth, whereas inducible-temporal regulation of secreted bone 
morphogenetic protein-2 drives osteogenesis in an on-demand manner. This 
approach enables stem cell technologies using material systems that host 
symbiotic interactions between eukaryotic and prokaryotic cells.
Stem Cell Engineering
Human mesenchymal stem cells (hMSCs) reside in niches, 
such as the bone marrow. These niches act to control hMSC 
quiescence, self-renewal, and differentiation upon regenerative 
demand.[1] As hMSCs are anchorage dependent, they receive 
critical information through the extracellular matrix (ECM) 
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medium.[16] Here we demonstrate a step change by engineering 
materials containing bacteria that express proteins constitu-
tively or triggered by an external stimulus. We show that these 
bacteria-based materials can be produced in 2D and 3D and 
offer new avenues to dynamic control of hMSCs.
Figure 1 illustrates a monolayer of engineered L. lactis that 
acts as an interface between synthetic materials and mamma-
lian cells (Figure 1A). L. lactis have been genetically modified to 
express FNIII7–10 that is covalently bound to the cell membrane 
to permit mammalian cell adhesion to the bacterial interface. 
Furthermore, BMP-2 is engineered so that it is either mem-
brane bound, i.e., presented from the interface, or secreted to the 
extracellular medium (from hereon denoted L. lactis-BMP-2M 
[membrane] and L. lactis-BMP-2S [secreted]) to induce osteogenic 
differentiation of hMSCs (Figure 1B). Importantly, these proteins 
can be synthesized in either a constitutive or inducible fashion, 
using the NIsin-controlled gene expression (NICE) system (nisA 
promoter), to provide dynamic-temporal control.[17]
FNIII7–10 contains the cell adhesion arginine-glycine-aspartic 
acid motif in the III10 module and the adhesion-synergy pro-
line-histidine-serine-arginine-asparagine (PHSRN) motif in 
the III9 module. These two motifs interact with integrins, 
particularly α5β1.[18] BMP-2 interacts with bone morphogenetic 
protein receptors (BMPRs) which leads to the activation of tran-
scription factors that drive the transcription of genes related to 
osteogenic differentiation.[19] Co-operation between integrin-
driven adhesion and BMP-2 signaling has been shown to be 
potently osteogenic.[20]
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Figure 1. Overview of the system and protein expression analysis (L. lactis NZ9020). A) L. lactis biofilms spontaneously develop on top of the material 
substrate displaying and secreting a variety of proteins and acting as an interface for hMSC attachment, proliferation, and differentiation. B) L. lactis 
engineered to express the III7–10 fragment of the human fibronectin (FNIII7–10) on its cell wall, fused to green fluorescent protein (GFP) as a reporter 
to initiate mammalian cell attachment. L. lactis can also be engineered to express BMP-2 as a membrane (BMP-2M) or secreted (BMP-2S) protein in a 
constitutive (left) or inducible (right) manner. BMP-2 signaling in mammalian cells leads to the activation of osteogenic transcription factors resulting 
in mesenchymal stem cell differentiation into osteoblasts. C) FN and BMP-2M were quantified via Western blot for both constitutive (left) and inducible 
(right) strains. Secreted BMP-2 was quantified by ELISA. Fresh GM17 growth media were inoculated with 20% overnight stationary phase culture and 
cultured for 1 h before the addition of nisin. Protein expression was measured after 5 h. Protein standards were used to construct a standard curve 
and concentrations were calculated from the regression analysis. These were quantified and plotted in ng mL−1 against nisin induction for: D) FN, 
E) BMP-2M, and F) BMP-2S. The dotted lines represent protein expression values in the constitutive strains.
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To confirm the expression of proteins by these interfaces, 
plasmids carrying the human FNIII7–10[21] and BMP-2 genes 
transformed to L. lactis strains were sequenced (data available 
in the Supporting Information) and protein expression was 
characterized using Western blot, enzyme-linked immuno-
sorbent assay (ELISA), or fluorometry (Figure 1C and Figure S1, 
Supporting Information). Samples from the constitutive strains 
(Figure 1C—constitutive) show the presence of FNIII7–10 
(L. lactis-FN), BMP-2M (L. lactis-BMP-2M) in the cell lysate, and 
BMP-2S (L. lactis-BMP-2S) in the supernatant (Figure S1D, Sup-
porting Information). Furthermore, and more importantly, the 
dynamic expression of these proteins in response to different 
concentrations of nisin is demonstrated in Figure 1C—inducible. 
Protein expression is dependent on the concentration of the 
inducer (nisin) (Figure 1D–F). These results confirm the func-
tionality of the cell environment by either membrane-bound or 
secreted proteins. Figure S1H in the Supporting Information 
shows the absolute protein expression values. We note that the 
amount of expressed protein is highly dependent on the strength 
of the promoter driving the expression. Notably, the nisA pro-
moter induced with saturating amounts of nisin produces higher 
expression levels compared to the constitutive P1 promoter.[22]
We assessed the use of two L. lactis strains, NZ9000 and 
NZ9020 at the cell/material interface. Both are derivatives of 
L. lactis MG1363,[23] with the nisRK nisin sensing genes inte-
grated in the pepN locus (genotype pepN::nisRK). This allows 
for the expression of the nisK sensor histidine kinase and 
nisR response regulator, required for nisin-induced gene 
expression[24] (Figure 1B). L. lactis NZ9020[23] lacks the lhdA and 
ldhB genes for lactate dehydrogenase, the last enzyme in the 
glycolytic pathway that metabolizes pyruvate to lactic acid.[25] 
Accumulation of lactic acid leads to medium acidification, 
which adversely affects the viability of the hMSCs. Without 
lactate dehydrogenase, L. lactis shifts its homofermentative 
glycolysis metabolism toward the production of acetoin as 
the main by-product with trace amounts of ethanol and other 
metabolites[23] (Figure S2E, Supporting Information). In the 
presence of oxygen, L. lactis switches its metabolism to aerobic 
respiration, using endogenous nicotinamide adenine dinucleo-
tide oxidase to maintain its redox balance. By supplementing 
hemin in the growth medium at low concentrations, 5 µg mL−1, 
the oxidation of NADH shifts to the electron transport chain[26] 
and the production of lactic acid is significantly reduced.
Prior to coculturing hMSCs and L. lactis, we investigated 
the viability of L. lactis biofilms on materials for 28 d, the 
time frame required to complete osteogenic differentiation in 
hMSCs.[27] As shown in a previous work,[28] the biofilms devel-
oped on glass are stable up to 4 d, whilst biofilms developed 
on a more hydrophobic surface as poly(ethyl acrylate) (PEA) 
are stable up to 28 d, the maximum time frame required for 
hMSCs to commit and differentiate to the osteogenic lineage. 
To reduce bacterial proliferation, sulfamethoxazole (SMX) 
was thus used at 5 µg mL−1 for the duration of the culture 
(Figure S2A,B, Supporting Information). Sulfamethoxazole 
is a bacteriostatic that blocks folate synthesis in bacteria, 
leading to a reduction in bacterial proliferation. Although the 
life cycle of a biofilm is limited, we found bacteria adhered to 
material substrates throughout the 28 d culture, with bacterial 
viability close to 70% (Figure S2A,B, Supporting Information). 
Determination of biofilm density on the surfaces used in this 
work, glass and PEA, was performed elsewhere[29] with values 
between 5 × 104 and 7.5 × 104 cfu mm−2, that correspond to a 
coverage of ≈9–14%. L. lactis produces biofilms that are usually 
one cell thick and do not fully cover the underlying substrate, 
as assessed by scanning electron microscopy on the surfaces 
tested in this work, namely glass, poly(ethyl acrylate), polycap-
rolactone (PCL), polyether ether ketone (PEEK), and titanium 
(Figure S4, Supporting Information). On the other hand, spe-
cies such as Staphylococcus aureus and Escherichia coli, amongst 
others, produce thicker biofilms with an evident presence of 
secreted matrix components. The presence of these extracel-
lular matrix components is less evident, if not totally absent, in 
the biofilms produced by L. lactis.
Next, hMSCs were cultured on L. lactis NZ9000 and 
NZ9020 biofilms expressing BMP-2M and BMP-2S, with 
L. lactis-FN, L. lactis-empty and FN-coated substrate as controls 
(FN-coated substrate and L. lactis-BMP-2S shown in Figure S3A, 
Supporting Information). After 28 d, hMSC viability values 
were higher than 95% for L. lactis NZ9020 (Figure 2B and 
Figure S2C, Supporting Information) and less than 40% for 
L. lactis NZ9000 (Figure S2D, Supporting Information) for all 
tested conditions, presumably due to the accumulation of lactic 
acid in the culture medium. The pH of the culture media of 
L. lactis NZ9020 and NZ9000, with and without hemin, was 
measured after 1 d of growth in both aerobic and anaerobic 
conditions (Figure S3B, Supporting Information). NZ9020 
grown aerobically with hemin produced the closest to neutral 
pH value (7.1). Based on these results, it was decided to use 
L. lactis NZ9020 for the hMSCs differentiation experiments. 
The dotted line represents pH 7.4, the closest growth condi-
tions to that of biological pH was reached by aerobic NZ9020 
with hemin at 5 µg mL−1.
We showed the ability of L. lactis to colonize a variety of 
different biomedical materials including polished titanium, 
PCL, and PEEK in 2D and 3D. Figure S4 in the Supporting 
Information shows that bacteria were able to form cfu biofilms 
with a heterogeneous structure and a thickness of one cell on 
all substrates, as assessed using scanning electron microscopy 
imaging.
hMSC adhesion to constitutive and inducible L. lactis-FN was 
tested after 5 h using increasing amounts of nisin (0, 0.5, 1, and 
10 ng mL−1). This led to increasing amounts of FNIII7–10 in the 
bacterial membrane as seen in Figure 1C,D and Figure S1A,B 
in the Supporting Information. In the interfaces with consti-
tutive FN expression, the presence of the FNIII7–10 fragment 
induced hMSC adhesion and focal adhesion development on 
at the bacteria/material interface, similar to the FN-coated sub-
strate, with cell areas of 2438 ± 245 and 3126 ± 165 µm2, respec-
tively (Figure 2A).[29] Importantly, the FN protein expression 
system controlled by nisin shows that hMSC area increased 
with increasing nisin concentration (FN values for both induc-
ible and constitutive expression in Figure 2A and Figure S5A 
in the Supporting Information are deduced from Western blot 
readings from Figure 1C and Figure S1A,B, Supporting Infor-
mation) with average cell areas of 1308 ± 120 µm2 without nisin 
induction and 2178 ± 129 µm2 inducing with 10 ng mL−1 of 
nisin (Figure 2C).[29] Importantly, the nisin-controlled FN pro-
tein expression system shows that hMSC area increased with 
Adv. Mater. 2018, 30, 1804310
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Figure 2. hMSC adhesion on L. lactis with inducible expression of FNIII7–10. A) hMSCs were cultured over different FNIII7–10—expressing strains of L. lactis for 
5 h. Top row shows cells attached to inducibly expressed FNIII7–10 under different concentrations of nisin. Bottom row shows hMSCs attached to constitutive 
expressing FN strains. FN-coated surfaces and glass were used as a positive and negative control respectively. hMSCs appear larger on samples where more 
FN is present. Scale bar is 100 µm. B) MSC viability on several L. lactis NZ9020 strains over 4 weeks. hMSC viability is roughly equivalent to that of an 
FN-coated substrate. C) Cell area of hMSCs was quantified from images in (A). Cell area increases upon additive amounts of nisin as more FN will be available 
to the hMSCs. The constitutive FNIII7–10 and FN-coated substrate also show much higher cell area than their empty and glass counterparts. Data were shown 
to be normally distributed and is presented as mean ± standard deviation (SD) and analyzed with analysis of variance (ANOVA) with a Tukey post hoc test. 
Significance levels are *p < 0.05, **p < 0.01, and *** p < 0.001 (symbols represent individual data points). D) Cell proliferation on all surfaces after 1 d. The 
data are not normally distributed and were therefore analyzed with a nonparametric ANOVA with a Bonferroni post hoc test (symbols represent individual 
data points). E) Alkaline phosphatase expression in hMSCs after a 12 d culture. Graph shows that the cells cocultured with L. lactis NZ9020 BMP2-S, which 
secretes ≈300 ng mL−1 of BMP-2 in the culture medium, show a comparable amount of ALP expression when compared to the control culture, which is an 
FN-coated surface with medium supplemented with 100 ng mL−1 of recombinant human BMP-2. The rest of the cultures, FN-coated glass, L. lactis-FN, and 
L. lactis-BMP2-M showed similar and statistically significantly lower values ALP activity values. These data suggest that the BMP-2 secreted by L. lactis, and only 
when secreted, is biologically active and induces the expression of alkaline phosphatase in hMSC. Data are presented as mean ± SD and was analyzed with 
a parametric ANOVA with a Tukey post hoc test. Significance levels are *p < 0.05, **p < 0.01, and *** p < 0.001 (symbols represent individual data points).
© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1804310 (5 of 8)
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Figure 3. Osteogenic differentiation of hMSCs on L. lactis (NZ9020) with inducible expression of BMP-2. A) The inducible cultures were tailored to 
express BMP-2 at different rates and FN in a constant fashion throughout the course of the experiment to test the longevity and time dependency 
of BMP-2 toward osteogenic differentiation. We used a biofilm prepared by mixing two different strains in a 1:1 ratio; one strain produces FN con-
stitutively, and the other secretes BMP-2 (L. lactis NZ9020 BMP-2S) in an inducible manner. Nisin was added daily to the cultures. A scatter plot of 
constant (green), high to low (red), and low to high (blue) induction profiles were chosen to test BMP-2S osteogenic activity. More information on 
the equation governing the induction profiles and the numerical values can be found in Table S1 in the Supporting Information. B) Levels of inducer 
(A) were related to absolute protein secretion as interpolated from (A). hMSCs were cultured on C) constitutive and D) inducible expressing bacteria 
for 21 d (OCN) and 28 d (von Kossa). At 21 d. hMSCs were stained for actin (red), osteocalcin (green), and nuclei (blue) and OCN was quantified. At 
28 d hMSC mineralization was studied. Black deposits corresponding to calcium phosphate deposition were imaged and quantified. Total integrated 
density corresponding to the green channel (osteocalcin) and black channel (phosphate) were quantified. Controls can be found in the Supporting 
Information. Top images show OCN and phosphate deposition as a fold change increase against FN-coated substrate (arbitrary value of 1, represented 
© 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1804310 (6 of 8)
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increasing nisin concentration (FN values for both inducible 
and constitutive expression in Figure 2A and Figure S5A in the 
Supporting Information are deduced from Western blot read-
ings from Figure 1C and Figure S1A,B, Supporting Informa-
tion) with average cell areas of 1308 ± 120 µm2 without nisin 
induction and 2178 ± 129 µm2 inducing with 10 ng mL−1 of 
nisin (Figure 2C).
hMSCs were cocultured on materials containing different 
L. lactis strains (constitutive FNIII7–10, BMP-2M and BMP-2S) 
and proliferating cells were measured using 5-bromo-2′-
deoxyuridine (BrdU) after 1 d coculture (Figure 2D). hMSCs on 
FN-coated substrates, L. lactis-FN and L. lactis-BMP-2M show 
high proliferation rates (≈10% of total cell count being BrdU 
positive). Conversely, lowest cell proliferation was seen on the 
FN-coated substrate samples cultured with BMP-2 control 
(100 ng mL−1 exogenous) of and L. lactis-BMP-2S, with less 
than 5% of cells being BrdU positive. No effect was found by 
fusing green fluorescent protein (GFP) to the expressed pro-
teins (GFP was used to assay protein concentration, Figure S6, 
Supporting Information); a similar trend was seen in a 3 d pro-
liferation experiment (Figure S6B, Supporting Information). 
These results indicate that hMSCs on materials containing 
L. lactis-BMP-2S are behaving in a similar manner to hMSCs 
on an FN-coated substrate cultured with media supplemented 
with 100 ng mL−1 BMP-2 and is in line with growth slow down 
with differentiation onset.[27,30]
hMSC differentiation was investigated at different time 
points; at 12 d by alkaline phosphatase (ALP) activity, at 21 d 
by osteocalcin (OCN) expression, and at 28 d by matrix min-
eralization assessment (von Kossa staining). ALP catalyzes the 
hydrolysis of phosphate esters and plays a key role in osteo-
blast activity and skeletal mineralization.[31] While L. lactis-FN 
and L. lactis-BMP-2M produced slightly increased levels of 
ALP compared to the control, L. lactis-BMP-2S produced sig-
nificantly higher levels, equivalent to the 100 ng mL−1 exog-
enous BMP-2 positive control (Figure 2E, GFP clones shown 
in Figure S7, Supporting Information). For the longer term 
experiments (Figure 3), different time-dependent induction 
profiles were set up to test the effectiveness of different con-
centrations of bacterially secreted BMP-2, as this is one of the 
key features of this material interface, i.e., the ability to con-
trol the temporal profile of expression of proteins that trigger 
hMSC differentiation. Thus, constant (green), high-to-low 
(red), and low-to-high (blue) BMP-2 expression profiles were 
tested as shown in Figure 3A and Table S1 in the Supporting 
Information. Figure 3B shows the amount of BMP-2 expressed 
by L. lactis-BMP-2S after addition of nisin interpolated from 
the ELISA values shown in Figure 1F. We note that this is the 
amount of BMP-2 secreted in the standard conditions meas-
ured in Figure 1—the characterization of our raw material—
and that the exact amount of BMP-2 secreted by bacteria in 
coculture with hMSCs might be slightly different, influenced 
by the conditions of the media.
OCN is regularly used as a marker for the onset of osteo-
genic commitment as it is expressed postproliferatively by 
osteoblasts.[32] Quantification of OCN (Figure 3C) showed 
higher expression in the 100 ng mL−1 BMP-2 positive control 
and in our constitutive L. lactis-BMP-2S interfaces. Deposition 
of phosphate, a marker of matrix mineralization denoting ter-
minal osteoblast differentiation was measured at day 28 using 
von Kossa staining (Figure 3C). Image analysis reveals sim-
ilar levels of mineralization between L. lactis-BMP-2S and 
the 100 ng mL−1 BMP-2, in good agreement with trends in 
proliferation, ALP, and OCN.
The dynamic character of the bacteria-based interface was 
used to investigate the temporal profile of BMP-2 delivery in 
relation to hMSC differentiation. Figure 3D shows hMSC dif-
ferentiation in response to our inducible strains by both OCN 
and von Kossa staining. The profiles shown in Figure 3B were 
used to highlight these dynamics. The data show that BMP-2 is 
most effective during early culture, as results for constant and 
high-to-low BMP-2 delivery lead to the same level of osteogenic 
differentiation. In contrast, expressing the same amount of 
BMP-2 in the later stages of the culture (low-to-high, Figure 3B) 
have no effect in triggering hMSC differentiation within this 
time course. This is in agreement with other studies that 
indicate BMP-2 signaling to be a very early stage osteogenic 
trigger.[30] Note that further OCN and von Kossa images are 
shown in Figures S8 and S9 in the Supporting Information, 
respectively. Together, all of these results demonstrate the 
potential of L. lactis-BMP-2S functionalized materials to pro-
mote hMSC differentiation.
L. lactis strains constitutively expressing BMP-2S driven by the 
P1 promoter were included in collagen sponges together with 
hMSCs to investigate adhesion and differentiation in 3D environ-
ments. Figure S10A in the Supporting Information shows that 
cells have attached to scaffolds functionalized with L. lactis bio-
films prepared from early log-phase cultures, which reach a final 
bacterial concentration of 2.23 × 109 cfu mL−1 in GM17, with 
much higher cell count than collagen only systems. hMSC dif-
ferentiation was quantified by ALP activity at day 15. Figure S10B 
in the Supporting Information shows that hMSCs in collagen 
sponges loaded with L. lactis-BMP-2S showed significantly 
increased osteogenic differentiation compared to collagen only 
and the other bacterial strains in agreement with 2D data.
L. lactis is a gram-positive lactic acid bacterium that has 
been used for centuries in food fermentation. Within the last 
35 years, significant progress has been made in using this 
organism, amongst other bacterial species in genetic engi-
neering for the therapeutic delivery of proteins.[33–38] For 
example, interleukin 27 has been expressed to alleviate the 
symptoms of colitis in mice.[39] Our work paves the way for 
Adv. Mater. 2018, 30, 1804310
by the horizontal dotted line on the graphs) on constitutively expressed L. lactis-BMP-2S. Bottom images show OCN and phosphate deposition as a 
fold change increase against FN-coated substrate on inducibly expressed L. lactis-BMP-2S under the three induction profiles shown. Graphs show OCN 
and phosphate with standard deviation of the sample sets, N ≥ 400 cells were analyzed for each condition. Data were shown to be normally distributed 
and is presented as mean ± SD. Data were analyzed using an ANOVA with a Tukey post hoc test. Scale bar is 100 µm in OCN images and 300 µm in 
von Kossa images. The dotted lines in graphs in (C) and (D) correspond to the value of the fold change for the negative control (FN-coated surface). 
Significance levels are **** p < 0.0001 (symbols represent individual data points).
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bacteria-based materials that enable hMSCs to be used in cell 
therapies. Current stem cell culture systems fall far short of 
desired outcomes of enhanced growth and enhanced prolifera-
tion that can work in a bioreactor-like manner.[40] Furthermore, 
these culture systems are not dynamic and might be good for 
growth[41] or differentiation[4,5] but not for both. Dynamic cul-
ture systems have been developed but are limited typically to 
simple on/off states.[6,11] Here we show how nonpathogenic bac-
teria such as L. lactis can be engineered and incorporated into 
material systems to allow temporal expression of membrane 
bound or secreted biologicals that can control hMSC growth 
(using FN) and differentiation (using BMP-2). It is easy to see 
how the complexity of this system can be tuned to express other 
proteins that could, e.g., drive other phenotypes. Further, the 
system is compatible with 3D materials, adherent stem cell cul-
tures, such as hMSCs, can be scaled to 3D “fermentation” type 
bioreactors for mass production of cells.
We focus on BMP-2 and osteogenic hMSC as a proof of con-
cept. Bone is the second most transplanted tissue after blood[42] 
and thus, there is a growing need for lab grown osteoblasts for 
cellular therapies. The ageing populations of many countries 
only exacerbates the problem as diseases such as osteoporosis 
are becoming more prevalent.[43] This work shows the osteo-
genic capabilities of genetically engineered bacteria in both 2D 
and 3D and on a variety of different materials (glass, polymers, 
hydrogels, and metal). We can coat these surfaces with BMP-2 
secreting L. lactis to induce highly efficient differentiation of 
hMSCs to osteoblasts in vitro, with 3D systems allowing us to 
envisage bioreactor scale cell production. These cells can then 
be harvested for a variety of downstream applications, ranging 
from autologous or allogenic cell transplants or for the creation 
of lab grown bone.[44]
Using these simple biological cells, the system could be 
improved as we created an environment whereby BMP-2 com-
pounded with other growth factors would assist in the crea-
tion of a bacterially expressed osteogenic “cocktail”. BMP-7, 
platelet-derived growth factor, and fibroblast growth factor are 
all known osteogenic factors that in addition to BMP-2 could be 
engineered into L. lactis to provide temporal controlled release 
and hence more efficient differentiation of hMSCs in a manner 
that would be extremely different to using conventional bio-
materials approaches. It is exactly this flexibility that is the real 
benefit concept. There are already a wide variety of constitutive 
and inducible expression systems available for L. lactis[45–47] and 
with these tools, one can create a plethora of on–off controlled 
material systems to deliver the protein of interest at a desired 
time point and dose. This would allow the creation of highly 
dynamic materials with a wide range of temporal information 
delivered to stem cells.
Here, we demonstrate the potential for use of bacteria-based 
material systems to control multiple facets of hMSC behavior. 
Even if responsive materials for cell engineering have been 
already developed and tested, radically, we use a broad range 
of materials (synthetic and natural substrates, in 2D and 3D 
culture systems) that are functionalized with genetically 
engineered bacteria to form bacteria-based materials. The 
nonpathogenic bacteria L. lactis has been modified to express 
a fragment of human FN as a membrane bound protein, to 
enable mammalian cell adhesion. In addition, the system 
has been further modified to express BMP-2, in a membrane 
bound and secreted form, under external induction. Whilst 
the membrane bound BMP-2 exhibited no osteogenic effect, 
secreted BMP-2 showed high levels of biological activity, being 
comparable to that of 100 ng mL−1 of BMP-2. Short, mid and 
long-term tests all showed the biological activity of L. lactis 
secreting BMP-2, creating a new paradigm in hMSC engi-
neering. These new materials can be instructed to produce 
biomolecules under demand, triggered by external stimuli. We 
foresee developments of this concept to produce large amounts 
of hMSCs in vitro and even adapting the system to be used in 
vivo in tissue engineering applications.
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